Transforming Biotherapeutics Development: A PAT-Ready Analytical Platform for Biopharma

|   Event

You are invited to register for our new webinar: Thursday, April 9th, at 9 AM (BST); 10 AM (CEST), or at 4 PM (BST); 5 PM (CEST)

Event

Beginning: 04/09/26

Location: Online

Two sessions are available for this webinar:

  • 9 AM BST / 10 AM CEST / 4 PM CST / 5 PM JST
  • 4 PM BST / 5 PM CEST / 8 AM PDT / 11 AM EDT
     

Biotherapeutics require precise structural characterization and stability monitoring throughout development and manufacturing. As biopharma moves toward greater process control and real-time quality assurance, analytical technologies must deliver rapid, information-rich data that support Process Analytical Technology (PAT) strategies.

In this webinar, we will present how Veloci, designed for regulated environments and powered by the innovative A-TEEMâ„¢ technology, serves as a powerful PAT-enabling tool for therapeutic protein analysis. Unlike conventional analytical methods that often require multiple techniques and lengthy workflows, Veloci combines absorbance and fluorescence measurements into a single, information-rich dataset, enabling detailed structural assessment, stability monitoring, and early aggregation detection with exceptional sensitivity.

Covered topics: Process analytical technology (PAT) - Critical quality attributes (CQA) - Upstream process control - Downstream analytics - At-line analysis

Key Learning Objectives

By the end of this webinar, participants will be able to:

  • Understand key analytical challenges in the structural and stability assessment of therapeutic proteins.
  • Appreciate how Veloci enhances structural insight and enables more comprehensive protein characterization compared to conventional techniques.
  • Evaluate the benefits of an integrated, single-workflow approach combining absorbance and fluorescence measurements.
  • Understand how Veloci supports regulatory compliance, including 21 CFR Part 11 requirements and OPC-UA connectivity for digital laboratory integration.
     

Who Should Attend:

  • Scientists in biopharmaceutical R&D and analytical development seeking advanced structural characterization of therapeutic proteins
  • Upstream and Downstream process development professionals seeking advanced analytical tools to support process optimization
  • Bioprocess and CMC professionals working on stability studies, comparability, and quality attribute assessment
  • PAT specialists and process engineers integrating real-time or at-line analytical technologies
  • QC managers and laboratory leaders implementing compliant, digitally integrated analytical workflows in regulated environments
     

Corporate